Low-level laser therapy inhibits bronchoconstriction, Th2 inflammation and airway remodeling in allergic asthma
- 28 January 2014
- journal article
- research article
- Published by Elsevier BV in Respiratory Physiology & Neurobiology
- Vol. 194, 37-48
- https://doi.org/10.1016/j.resp.2014.01.008
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- AsthmaSeminars in Respiratory and Critical Care Medicine, 2012
- Low-Level Laser Therapy Activates NF-kB via Generation of Reactive Oxygen Species in Mouse Embryonic FibroblastsPLOS ONE, 2011
- Low-level laser therapy (LLLT) acts as cAMP-elevating agent in acute respiratory distress syndromeLasers in Medical Science, 2010
- Low-level laser therapy (LLLT; 780 nm) acts differently on mRNA expression of anti- and pro-inflammatory mediators in an experimental model of collagenase-induced tendinitis in ratLasers in Medical Science, 2010
- The proximal STAT6 and NF-κB sites are responsible for IL-13- and TNF-α-induced RhoA transcriptions in human bronchial smooth muscle cellsPharmacological Research, 2010
- Low-level laser therapy (LLLT) attenuates RhoA mRNA expression in the rat bronchi smooth muscle exposed to tumor necrosis factor-αLasers in Medical Science, 2010
- Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trialsThe Lancet, 2009
- Biphasic Dose Response in Low Level Light TherapyDose-Response, 2009
- Infrared Laser Therapy for Ischemic Stroke: A New Treatment StrategyStroke, 2007
- Effect of LLLT Ga–Al–As (685 nm) on LPS-induced inflammation of the airway and lung in the ratLasers in Medical Science, 2005